<DOC>
	<DOCNO>NCT00207792</DOCNO>
	<brief_summary>The effect haematopoietic growth factor neutrophil recovery allogeneic bone marrow transplantation well recognize . Recent laboratory study demonstrate cytokine may also modify T-cell dendritic cell function , whether effect strong enough alter risk graft-versus-host disease ( GvHD ) unclear . The aim randomise study determine effect granulocyte colony-stimulating factor [ G-CSF ] ( Neupogen ; filgrastim ) risk acute GvHD allogeneic bone marrow transplantation .</brief_summary>
	<brief_title>Trial Filgrastim Versus Placebo Following Allogeneic Bone Marrow Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Age : &gt; 16 year &lt; 46 year Genoidentical allogeneic bone marrow transplantation Myeloablative conditioning regimen Haematological malignancy acquire aplastic anemia Written inform consent ECOG performance score &gt; 2 Tcell depletion Serum creatinine level &gt; 133 Âµmol/L Abnormal liver function Positive HIV test Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>Granulocyte colony stimulate factor</keyword>
</DOC>